Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 1
1910 2
1948 1
1951 2
1957 1
1962 1
1972 1
1976 2
1977 2
1979 1
1985 1
1989 2
1994 1
1996 2
1997 1
1998 1
1999 2
2000 3
2002 1
2003 4
2004 1
2007 2
2008 5
2009 10
2010 14
2011 8
2012 6
2013 5
2014 1
2015 4
2016 4
2020 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
Winans T, Oaks Z, Choudhary G, Patel A, Huang N, Faludi T, Krakko D, Nolan J, Lewis J, Blair S, Lai Z, Landas SK, Middleton F, Asara JM, Chung SK, Wyman B, Azadi P, Banki K, Perl A. Winans T, et al. Among authors: wyman b. J Autoimmun. 2023 Sep 22;140:103112. doi: 10.1016/j.jaut.2023.103112. Online ahead of print. J Autoimmun. 2023. PMID: 37742509
Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation.
Huang N, Winans T, Wyman B, Oaks Z, Faludi T, Choudhary G, Lai ZW, Lewis J, Beckford M, Duarte M, Krakko D, Patel A, Park J, Caza T, Sadeghzadeh M, Morel L, Haas M, Middleton F, Banki K, Perl A. Huang N, et al. Among authors: wyman b. Nat Commun. 2024 Mar 22;15(1):2598. doi: 10.1038/s41467-024-46441-2. Nat Commun. 2024. PMID: 38519468 Free PMC article.
Disease progression modeling using Hidden Markov Models.
Sukkar R, Katz E, Zhang Y, Raunig D, Wyman BT. Sukkar R, et al. Among authors: wyman bt. Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:2845-8. doi: 10.1109/EMBC.2012.6346556. Annu Int Conf IEEE Eng Med Biol Soc. 2012. PMID: 23366517
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.
Novak G, Fox N, Clegg S, Nielsen C, Einstein S, Lu Y, Tudor IC, Gregg K, Di J, Collins P, Wyman BT, Yuen E, Grundman M, Brashear HR, Liu E. Novak G, et al. Among authors: wyman bt. J Alzheimers Dis. 2016;49(4):1123-34. doi: 10.3233/JAD-150448. J Alzheimers Dis. 2016. PMID: 26639957 Clinical Trial.
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Liu E, et al. Among authors: wyman bt. Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24. Neurology. 2015. PMID: 26208959 Free PMC article. Clinical Trial.
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials.
Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, Lobello K, Li D, McRae T, Lucas P, Evans I, Booth K, Luscan G, Wyman BT, Hua L, Yang L, Brashear HR, Black RS; Bapineuzumab 3000 and 3001 Clinical Study Investigators. Vandenberghe R, et al. Among authors: wyman bt. Alzheimers Res Ther. 2016 May 12;8(1):18. doi: 10.1186/s13195-016-0189-7. Alzheimers Res Ther. 2016. PMID: 27176461 Free PMC article. Clinical Trial.
85 results